Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of suvorexant in severe sleep apnea syndrome
jRCTs041180086Completed
- Start
- Dec 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of suvorexant in sleep apnea. Primary endpoint: Apnea hypopnea index on PSG. Started Dec 2016; status: completed.
02
Drugs
suvorexant
03
Conditions
sleep apnea
Beyond the preview
Go deeper on jRCTs041180086.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs041180086.